Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for Early-Onset Preeclampsia
NCT07738562Phase 2Not yet recruiting
- Sponsor
- Hadassah Medical Organization
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of dipyridamole in preeclampsia, sponsored by Hadassah Medical Organization. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dipyridamole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07738562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738562.